aid: celea-therapeutics

name: Celea Therapeutics

image: http://static1.squarespace.com/static/68f24efd0976f3155cb544a1/t/69011232979bd576aa553264/1761677874337/Celea_Logo_RGB.png?format=1500w

description: 'Celea Therapeutics is a biopharmaceutical company focused on developing next‑generation therapies for serious respiratory diseases, notably idiopathic pulmonary fibrosis. Their lead program deupirfenidone is in Phase 3, aiming to become a new standard of care. The company emphasizes patient‑centric science and innovative drug development.'

url: https://raw.githubusercontent.com/api-evangelist/celea-therapeutics/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-07'

modified: '2026-10-07'

tags:
- Company
- Biopharma
- Respiratory
- IPF
- Therapeutics

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/celea-therapeutics-hosts.yml
- type: Vendors
  url: vendors/celea-therapeutics-vendors.yml
- type: Newsroom
  url: https://www.celeatx.com/news
- type: DomainSecurity
  url: security/celea-therapeutics-domain-security.yml
- type: Website
  url: https://www.celeatx.com

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  detail: No API or developer documentation was found for Celea Therapeutics.
  evidence:
    - url: https://api.celeatx.com/openapi.json
      status: 0
  checked: '2026-10-07'
x-enrichment:
  date: '2026-10-07'
  status: enriched
  artifacts_added: 4
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local